Drug Discovery Articles
Medicure expands antithrombics accord
16 January 2006
Scynexis Europe spins off to become Selcia
9 January 2006
Galapagos extends deal with Amgen through 2006
12 December 2005
ReNeuron reports losses of $L4.3 million
12 December 2005
Evotec's first milestone from Takeda
12 December 2005
New CEO and chairman for France's Hybrigenics
5 December 2005
Xantos gets gov development grant
5 December 2005
Pharma/biotech adopt outsourcing to fight rising costs
5 December 2005
Isis claims $4M from Novartis/Alnylam accord
19 September 2005
BioFocus launches new first-in-class azetidine library
19 September 2005
Avalon and Novartis' drug discovery collaboration
19 September 2005
MorphoSys licenses HuCAL to Shionogi
19 September 2005
Arrow receives first IND for RSV treatment
19 September 2005
MultiCell forms new company
19 September 2005
Nuvelo begins Alfimeprase Ph III trials
12 September 2005
OncoMed Pharma raises $13.9M to develop new therapeutics
12 September 2005
Ranbaxy Laboratories opens drug discovery center in India
5 September 2005
Pharmacopeia and Organon extend collaboration
5 September 2005
Renin co-crystallization to speed cardio drug discovery
22 August 2005
Pfizer acquires privately-held Bioren
22 August 2005
Michael J Fox Foundation award for Alnylam
22 August 2005
MDS Pharma expands research capacity in Nebraska
22 August 2005
TCS and Congenia ink lead optimization deal
15 August 2005
Isis and Lilly extend antisense R&D accord
15 August 2005
Almirall enters drug discovery alliance with Sareum
15 August 2005
Elan helps inaugurate AD research fund program
8 August 2005
Aptanomics to validate targets for Boeh Ingelheim
8 August 2005
MerLion and Merck & Co expand deal
1 August 2005
VASTox commences SMA program
1 August 2005
Invitrogen opens cGMP facility in Australia
25 July 2005
Patients complete therapy in Medicure's Ph II trial
25 July 2005
Stem Cell Sciences falls short of IPO target
25 July 2005
BrainCells in $17.7M financing round
25 July 2005
Medicure's MEND-CABG completes enrollment
18 July 2005
Galapagos and Novartis enter agreement
18 July 2005
Karo Bio losses rise and revenues slump
18 July 2005
Inpharmatica launches protein annotation platform
18 July 2005
Morphochem and GC reach AD milestone
18 July 2005
Genentech announces three appointments
11 July 2005
Structural GenomiX and CFF in $15M alliance
11 July 2005
Obesity and diabetes seen as accelerated aging
11 July 2005
Paradigm signs R&D accord with J&J
11 July 2005
VASTox signs new service contract deal
27 June 2005
Medarex posts amendments with SEC
20 June 2005
TopoTargets completes IPO
20 June 2005
AUREUS extends deal with Sanofi-Aventis
13 June 2005
Exelixis and Genentech enter R&D accord
13 June 2005
GeneLogic renews BioExpress deals
13 June 2005
Exelixis and Genentech enter R&D accord
13 June 2005
Inpharmatica licenses drug tools to Serono
13 June 2005
Evotec income up 10% in 1st qtr
6 June 2005
Astex gets approval for PhI trial of AT7519
30 May 2005
Inpharmatica launches GPCR database
30 May 2005
Pharmacopeia gets milestone payment from Organon
30 May 2005
Praecis cuts workforce 60% in reshuffle
30 May 2005
IT's role in evolving pharma industry
30 May 2005
GSK creates Center of Excellence
30 May 2005
Hybrigenics gains quality certification
23 May 2005
EiRx ups its stake in Auvation to 95%
23 May 2005
NiKem and Hybrigenics expand R&D accord
23 May 2005
ExonHit and Allergan extend alliance
23 May 2005
Lexicon and Organon in biotherapeutics alliance
23 May 2005
Odyssey expands deal with Pfizer
23 May 2005
Idenix increases R&D in Montpellier
16 May 2005
Positive preclinical data for Medicure drug
16 May 2005
MorphoSys revenues leap 72% in 1st qtr
9 May 2005
Antisense drugs get thumbs-up from Isis
9 May 2005
Anacor Pharma recruits Karl Beutner as CMO
28 April 2005
German govt funding for GPC Biotech and Ingenium
26 April 2005
Cisbio debuts GOCR-Gq assay
26 April 2005
ID Business Solutions in accord with Vitra Bioscience
25 April 2005
Galapagos forms alliance with CFFT
25 April 2005
CeNeS and Tripos advance COMT deal
25 April 2005
MerLion and Sankyo sign drug R&D deal
22 April 2005
Study of Medicure's MC-1 continues
22 April 2005
BioSource rejects Bio-Rad offer
18 April 2005
Japan's most-admired pharma companies: NPP survey
18 April 2005
Trigen and ProCorde to merge
18 April 2005
Nuvelo begins R&D collaboration with Kirin Brewery
11 April 2005
EiRx ups stake in Auvation
11 April 2005
ESBATech and Novartis form research alliance
4 April 2005
Pharmacopeia and CV Therapeutics form alliance
4 April 2005
Japan stock market week to March 28
4 April 2005
Sweden's Biovitrum acquires Cambridge Biotechnology
28 March 2005
Ranbaxy reveals restructuring plan
21 March 2005
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
